Xueding Wang

1.9k total citations
97 papers, 1.4k citations indexed

About

Xueding Wang is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Xueding Wang has authored 97 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 23 papers in Pediatrics, Perinatology and Child Health and 22 papers in Molecular Biology. Recurrent topics in Xueding Wang's work include Pharmacological Effects and Toxicity Studies (20 papers), Drug Transport and Resistance Mechanisms (17 papers) and Pharmacogenetics and Drug Metabolism (15 papers). Xueding Wang is often cited by papers focused on Pharmacological Effects and Toxicity Studies (20 papers), Drug Transport and Resistance Mechanisms (17 papers) and Pharmacogenetics and Drug Metabolism (15 papers). Xueding Wang collaborates with scholars based in China, United States and Australia. Xueding Wang's co-authors include Min Huang, Lihong V. Wang, Gang Yao, Huichang Bi, Jiali Li, Jiali Li, Changxi Wang, Chia-Wei Sun, Qian Fu and C. C. Yang and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Scientific Reports.

In The Last Decade

Xueding Wang

92 papers receiving 1.4k citations

Peers

Xueding Wang
Gabriele Kirchner Germany
Wolfgang Jacobsen United States
Takashi Saeki Japan
Edmund J.D. Lee Singapore
Julia M. Barbarino United States
Jacky Vonderscher Switzerland
Patrick Caron Canada
Darlene Barr United States
Richard E. Mullins United States
Alberto Tejedor Spain
Gabriele Kirchner Germany
Xueding Wang
Citations per year, relative to Xueding Wang Xueding Wang (= 1×) peers Gabriele Kirchner

Countries citing papers authored by Xueding Wang

Since Specialization
Citations

This map shows the geographic impact of Xueding Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueding Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueding Wang more than expected).

Fields of papers citing papers by Xueding Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueding Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueding Wang. The network helps show where Xueding Wang may publish in the future.

Co-authorship network of co-authors of Xueding Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xueding Wang. A scholar is included among the top collaborators of Xueding Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueding Wang. Xueding Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xueding, Yang Liu, Zhiyuan Ren, et al.. (2024). Biomechanical properties of articular cartilage in different regions and sites of the knee joint: acquisition of osteochondral allografts. Cell and Tissue Banking. 25(2). 633–648. 4 indexed citations
2.
Park, Sumin, Van Phuc Nguyen, Xueding Wang, & Yannis M. Paulus. (2024). Gold Nanoparticles for Retinal Molecular Optical Imaging. International Journal of Molecular Sciences. 25(17). 9315–9315. 5 indexed citations
3.
Chen, Xi, Wen Xie, Wenfeng Fang, et al.. (2024). Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non–Small Cell Lung Cancer. Clinical Cancer Research. 30(7). 1382–1396. 2 indexed citations
4.
Liu, Shu, et al.. (2023). Development and validation of a sensitive LC–MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patients. Journal of Pharmaceutical and Biomedical Analysis. 237. 115758–115758. 6 indexed citations
5.
Mao, Jing, Xiaoping Ye, Xia Zhu, et al.. (2023). Comparison and development of machine learning for thalidomide-induced peripheral neuropathy prediction of refractory Crohn’s disease in Chinese population. World Journal of Gastroenterology. 29(24). 3855–3870. 3 indexed citations
6.
7.
Chen, Xi, Wen Xie, Heng Liang, et al.. (2022). FOXM1 Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non–Small Cell Lung Cancer. Clinical Cancer Research. 28(17). 3770–3784. 32 indexed citations
8.
Zhou, Shan, Ziyi Chen, Xueding Wang, et al.. (2022). LC–MS/MS quantification of levetiracetam, lamotrigine and 10‐hydroxycarbazepine in TDM of epileptic patients. Biomedical Chromatography. 36(8). e5393–e5393. 7 indexed citations
9.
Fang, Wenfeng, Jianwen Li, Delan Li, et al.. (2021). Impact of STAT1 polymorphisms on crizotinib-induced hepatotoxicity in ALK-positive non-small cell lung cancer patients. Journal of Cancer Research and Clinical Oncology. 147(3). 725–737. 12 indexed citations
10.
11.
Liu, Shu, He Huang, Rongxin Chen, et al.. (2020). Low initial trough concentration of rituximab is associated with unsatisfactory response of first-line R-CHOP treatment in patients with follicular lymphoma with grade 1/2. Acta Pharmacologica Sinica. 42(4). 641–647. 5 indexed citations
12.
Guan, Su, Kang Chao, Xia Zhu, et al.. (2019). UPLC–QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis. Journal of Proteome Research. 19(2). 600–609. 47 indexed citations
13.
Ma, Yuxiang, Qingguang Lin, Wei Zhuang, et al.. (2019). The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a prospective cohort study. Annals of Translational Medicine. 7(24). 806–806. 14 indexed citations
14.
Cai, Dake, Yao Liu, Min Zhi, et al.. (2018). A validated LC–MS/MS method for the simultaneous determination of thalidomide and its two metabolites in human plasma: Application to a pharmacokinetic assay. Biomedical Chromatography. 32(8). e4240–e4240. 5 indexed citations
15.
Liu, Shu, Rongxin Chen, Jun Li, et al.. (2016). The POR rs1057868–rs2868177 GC-GT diplotype is associated with high tacrolimus concentrations in early post-renal transplant recipients. Acta Pharmacologica Sinica. 37(9). 1251–1258. 15 indexed citations
16.
Zhou, Yafang, Xueding Wang, Hongliang Li, et al.. (2015). Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients. Drug Metabolism and Pharmacokinetics. 30(4). 282–287. 40 indexed citations
17.
Wang, Yixi, Jiali Li, Xueding Wang, et al.. (2015). Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation. Acta Pharmacologica Sinica. 36(7). 855–862. 4 indexed citations
18.
Zhang, Jie, Xueding Wang, Zhuojia Chen, et al.. (2013). Rapid determination of lamotrigine in human plasma by HPLC method. Zhongguo jiceng yiyao. 20(11). 1601–1603. 1 indexed citations
19.
20.
Wang, Xueding, Jiali Li, Xiǎoyīng Dèng, et al.. (2007). A Pharmacogenetic Study of Pregnane X Receptor (NR1I2) in Han Chinese. Current Drug Metabolism. 8(8). 778–786. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriele Kirchner Breakdown of academic impact, for papers by Wolfgang Jacobsen Breakdown of academic impact, for papers by Takashi Saeki Breakdown of academic impact, for papers by Edmund J.D. Lee Breakdown of academic impact, for papers by Julia M. Barbarino Breakdown of academic impact, for papers by Jacky Vonderscher Breakdown of academic impact, for papers by Patrick Caron Breakdown of academic impact, for papers by Darlene Barr Breakdown of academic impact, for papers by Richard E. Mullins Breakdown of academic impact, for papers by Alberto Tejedor
Rankless by CCL
2026